[1]
Gautam, N. and Mishra, A. 2019. Formulation and Characterization of Repaglinide Chitosan Nanoparticles for the Treatment of Diabetes Mellitus Type II. Current Research in Pharmaceutical Sciences. 8, 4 (Jan. 2019), 270-277. DOI:https://doi.org/10.24092/CRPS.2018.080402.